Efficacy and safety of semaglutide in non-alcoholic fatty liver disease

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease. The prevalence and disease burden of NAFLD are projected to exponentially increase resulting in significant healthcare expenditures and lower health-related quality of life. To date, there are no app...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Kai, Kakkar, Rohan, Chahal, Daljeet, Yoshida, Eric M, Hussaini, Trana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600803/
https://www.ncbi.nlm.nih.gov/pubmed/37899788
http://dx.doi.org/10.3748/wjg.v29.i37.5327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600803/
https://www.ncbi.nlm.nih.gov/pubmed/37899788
http://dx.doi.org/10.3748/wjg.v29.i37.5327

Ejemplares similares